Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Living with Legacy: Outcomes and Future Implications for Offspring of Patients with MEN1.

Journal of the ASEAN Federation of Endocrine Societies·2026
Same author

Consensus on acromegaly complications: an update.

Pituitary·2026
Same author

Impulse control disorders and dopamine agonists.

Best practice & research. Clinical endocrinology & metabolism·2026
Same author

Reproductive and sexual sequelae of neuroendocrine tumour therapies: an under-recognised challenge.

Endocrine-related cancer·2026
Same author

Case Report: Rare pheochromocytoma in a patient with Li-Fraumeni syndrome: a 3-event, 4-hit model of pathogenesis.

Frontiers in oncology·2026
Same author

Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours.

Journal of neuroendocrinology·2026

Related Experiment Video

Updated: Apr 25, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.5K

Clinical review: Functioning gonadotroph adenomas.

Georgia Ntali1, Cristina Capatina, Ashley Grossman

  • 1Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, Oxford OX3 7LJ, United Kingdom.

The Journal of Clinical Endocrinology and Metabolism
|August 29, 2014
PubMed
Summary

Functioning gonadotroph adenomas (FGAs) are rare pituitary tumors. Surgical removal is primary treatment, but long-term follow-up is essential due to recurrence risk.

More Related Videos

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
07:37

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

Published on: August 16, 2024

2.1K
Dual Somatic Recordings from Gonadotropin-Releasing Hormone GnRH Neurons Identified by Green Fluorescent Protein GFP in Hypothalamic Slices
09:30

Dual Somatic Recordings from Gonadotropin-Releasing Hormone GnRH Neurons Identified by Green Fluorescent Protein GFP in Hypothalamic Slices

Published on: February 23, 2010

23.7K

Related Experiment Videos

Last Updated: Apr 25, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.5K
Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
07:37

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

Published on: August 16, 2024

2.1K
Dual Somatic Recordings from Gonadotropin-Releasing Hormone GnRH Neurons Identified by Green Fluorescent Protein GFP in Hypothalamic Slices
09:30

Dual Somatic Recordings from Gonadotropin-Releasing Hormone GnRH Neurons Identified by Green Fluorescent Protein GFP in Hypothalamic Slices

Published on: February 23, 2010

23.7K

Area of Science:

  • Endocrinology
  • Oncology
  • Neurosurgery

Background:

  • Functioning gonadotroph adenomas (FGAs) are rare pituitary tumors secreting active gonadotropins.
  • Existing literature consists primarily of small case series and individual case reports.
  • This review synthesizes available data to guide patient follow-up.

Purpose of the Study:

  • To review and summarize published data on functioning gonadotroph adenomas (FGAs).
  • To provide guidance on the follow-up of patients diagnosed with FGAs.
  • To consolidate understanding of this rare pituitary tumor entity.

Main Methods:

  • Comprehensive literature search of English articles in PubMed up to December 2013.
  • Utilized search terms including "functioning gonadotroph adenomas," "FSH secreting adenomas," and "LH secreting adenomas."
  • Reviewed presenting manifestations, management strategies, and long-term outcomes of reported FGA cases.

Main Results:

  • Functioning gonadotroph adenomas present with distinct clinical manifestations.
  • Most reported FGAs are macroadenomas.
  • Pathogenesis of FGAs remains largely unknown.

Conclusions:

  • Surgical excision is the primary therapeutic approach for FGAs.
  • Long-term clinical and imaging surveillance is crucial due to the risk of tumor recurrence.
  • Radiotherapy may be considered; medical therapies show limited efficacy for tumor control.